CONTINUING EDUCATION:
RN, NP:  .75 CE Credit

Recorded Date:  April 12, 2014 (as part of the 2014 PCNA annual symposium in Atlanta)
Original Posting Date: March 2, 2016
Content Reviewed Date: February 2017

COURSE OVERVIEW:

Dr. Nanette Wenger outlines the evidence for pregnancy complications as markers of future CVD risk.

AUDIENCE:
Nurses, advanced practice nurses, and other healthcare providers interested in the prevention and management of cardiovascular disease.

FACULTY DISCLOSURES:
The faculty members have declared no commercial relationships related to the content of this presentation.

COST:
This online educational activity is offered free of charge.

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the course materials; complete the post-test (you can take the post-test more than once if needed to achieve a passing score of 75%) and online evaluation form at the end of the activity, and print your CE certificate.

ACCREDITOR:
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Association of Nurse Practitioners (AANP) as an approved provider of Nurse Practitioner continuing education, provider number 030602. 

Please note that if you received credit for attending the 2014 PCNA Annual Symposium in Atlanta, you will be unable to claim credit for the on-demand sessions that were recorded there.  

Explain how the identification of pregnancy associated hypertension and gestational diabetes can help drive strategies for CVD risk reduction.